BLAU FARMACÊUTICA S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.89 BRL | +5.36% |
|
+0.83% | -33.64% |
| 03-20 | Transcript : Blau Farmacêutica S.A., Q4 2023 Earnings Call, Mar 20, 2024 | |
| 03-19 | Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Blau Farmacêutica S.A.
6cf48fe096e1faafba7320e.dn2W4_YlUvkY0i6oltjMvm3Q8KMcIdRyVCoPJDLzqTg.IgjakY5MA511437c94Kr_Fzhx-lxapMFB3JHZnmE5mwSG6Ct23EllG2jew~8845023da4d43619997488131cd05d7e
Upcoming events on Blau Farmacêutica S.A.
Past events on Blau Farmacêutica S.A.
| 08/05/2024 14:00 | Q1 2024 Earnings Call |
| 06/05/2024 | Q1 2024 Earnings Release After hours |
| 28/04/2024 | Annual General Meeting |
| 20/03/2024 13:00 | Q4 2023 Earnings Call |
| 18/03/2024 | Q4 2023 Earnings Release After hours |
| 14/11/2023 17:30 | Extraordinary Shareholders Meeting |
| 09/11/2023 14:00 | Q3 2023 Earnings Call |
| 07/11/2023 | Q3 2023 Earnings Release After hours |
| 10/08/2023 14:00 | Q2 2023 Earnings Call |
| 08/08/2023 | Q2 2023 Earnings Release After hours |
| 05/05/2023 14:00 | Q1 2023 Earnings Call |
| 03/05/2023 | Q1 2023 Earnings Release After hours |
| 18/04/2023 | Annual General Meeting |
| 02/03/2023 13:00 | Q4 2022 Earnings Call |
| 28/02/2023 | Q4 2022 Earnings Release After hours |
| 21/11/2022 11:30 | Investor Day |
| 04/11/2022 13:00 | Q3 2022 Earnings Call |
| 02/11/2022 | Q3 2022 Earnings Release After hours |
| 02/08/2022 14:00 | Interim 2022 Earnings Call |
| 31/07/2022 | Interim 2022 Earnings Release After hours |
Past dividends on Blau Farmacêutica S.A.
| 29/04/2024 | Interim Payment 0.0139834 BRL |
| 24/03/2024 | Other Dividend 0.125218 BRL |
| 27/06/2023 | Other Dividend 0.0694395 BRL |
| 27/06/2023 | Other Dividend 0.117519 BRL |
| 19/04/2023 | Annual 0.052393 BRL |
| 26/03/2023 | Other Dividend 0.182978 BRL |
| 21/12/2022 | Other Dividend 0.17654 BRL |
| 26/09/2022 | Other Dividend 0.1681432 BRL |
| 07/07/2022 | Other Dividend 0.1603348 BRL |
| 07/04/2022 | Other Dividend 0.1391133 BRL |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million BRL | Released Forecast Spread | 1 182 | 1 366 1 380 -0.97% | 1 407 1 501 -6.28% | 1 373 1 377 -0.3% | 1 599 |
|
EBITDA Million BRL | Released Forecast Spread | 0,00 | 478 508 -5.97% | 474 509 -6.94% | 368 343 7.43% | 328 |
|
EBIT Million BRL | Released Forecast Spread | 0,00 | 457 485 -5.91% | 452 493 -8.21% | 329 323 1.89% | 292 |
|
Earnings before Tax (EBT) Million BRL | Released Forecast Spread | 0,00 | 0,00 0,00 - | 469 542 -13.53% | 334 300 11.41% | 286 |
|
Net income Million BRL | Released Forecast Spread | 0,00 | 325 387 -15.92% | 363 387 -6.11% | 250 248 0.77% | 201 |
|
EPS BRL | Released Forecast Spread | 1,61 | 1,89 2,31 -18.02% | 2,04 2,20 -7.26% | 1,41 1,33 6.25% | 1,12 |
| Announcement Date | 05/02/21 | 21/02/22 | 01/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million BRL | Released Forecast Spread | 313 312 0.32% | 365 371 -1.55% | 362 368 -1.86% | 367 392 -6.51% | 258 307 -16.01% | 364 376 -3.02% | 363 388 -6.48% | 387 367 5.54% | 360 363 -1.05% | 402 | 404 | 407 |
|
EBITDA Million BRL | Released Forecast Spread | 115 111 4.27% | 121 121 -0.21% | 119 123 -3.58% | 120 119 1.18% | 58,0 76,1 -23.78% | 94,2 101 -6.37% | 164 92,4 77.35% | 52,0 51,7 0.6% | 65,0 57,1 13.78% | 72,8 | 94,3 | 97,5 |
|
EBIT Million BRL | Released Forecast Spread | 115 130 -11.64% | 113 116 -2.82% | 114 151 -24.48% | 51,3 146 -64.96% | 86,2 107 -19.15% | 152 99,4 53.24% | 39,5 36,3 8.7% | 48,8 50,0 -2.42% | 67,6 | 73,5 | 75,0 | |
|
Earnings before Tax (EBT) Million BRL | Released Forecast Spread | 38,0 | |||||||||||
|
Net income Million BRL | Released Forecast Spread | 61,5 63,0 -2.44% | 112 100 11.92% | 94,5 93,2 1.39% | 95,0 92,0 3.24% | 52,0 65,0 -20.08% | 70,8 74,3 -4.77% | 99,4 67,7 46.89% | 27,7 31,7 -12.61% | 40,1 31,5 27.27% | |||
|
EPS BRL | Released Forecast Spread | 0,63 0,56 13.47% | 0,42 0,57 -26.03% | 0,53 0,64 -17.63% | 0,40 0,46 -13.62% | 0,56 0,43 30.23% | 0,16 0,50 -67.76% | 0,23 0,18 28.39% | 0,23 | 0,27 | 0,31 | ||
| Announcement Date | 09/05/22 | 01/08/22 | 03/11/22 | 01/03/23 | 05/05/23 | 09/08/23 | 09/11/23 | 19/03/24 | 07/05/24 | - | - | - |
More events
Past sector events for Blau Farmacêutica S.A.
| 16/05/2024 | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 15:05 | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 06:30 | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 15/05/2024 12:40 | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 15/05/2024 08:03 | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 14/05/2024 22:43 | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 09:52 | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 14/05/2024 06:30 | BAYER AG: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BLAU3 Stock
- Calendar Blau Farmacêutica S.A.
